Abstract
BackgroundAdoptive T-cell therapy has demonstrated clinical activity in B-cell malignancies, offering hope for its application to a broad spectrum of cancers. However, a significant portion of patients with solid tumors...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have